Back to results
US 12,433,896 B2Granted
Deuterated analogs of etifoxine, their derivatives and uses thereof
AssigneeGaba Therapeutics Inc.
InventorOlivier Dasse
Life of this patent
Estimating the term…
Abstract
This invention relates to deuterated analogs of etifoxine of Formula 1, solvates, prodrugs, and pharmaceutically acceptable salts thereof, as well as to methods for their preparation and use, and to pharmaceutical compositions. Briefly, this invention is generally directed to deuterated analogs of etifoxine as well as to methods for their preparation and use, and to pharmaceutical compositions containing the same.
Claims6
A method of treating a convulsive disorder in a subject in need thereof comprising administering to said subject an effective amount of a compound of Formula II:
- or pharmaceutically acceptable salt thereof, wherein:
- each X1 is independently hydrogen or deuterium.
Dependencies are inferred from the claim text.